Anzeige
Meldung des Tages: Das Team hinter UberDoc! Warum Paula Muto, M.D. - und dieses Führungsteam - der eigentliche Katalysator sein könnten

Ginkgo Bioworks News

Aktie
WKN:  A40KL9 ISIN:  US37611X2099 US-Symbol:  DNA Branche:  Biotechnologie Land:  USA
7,70 $
+1,02 $
+15,27%
6,5270 € 19:19:56 Uhr
Depot/Watchlist
Marktkapitalisierung *
346,22 Mio. €
Streubesitz
25,08%
KGV
-1,44
Index-Zuordnung
-

Ginkgo Bioworks News

02.03.26 - PR Newswire
Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure
Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure PR Newswire
26.02.26 - PR Newswire
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity ...
19.02.26 - PR Newswire
Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation
Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation PR Newswire
18.02.26 - PR Newswire
Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products
Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-​based Agricultural Products PR Newswire
05.02.26 - PR Newswire
Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark
Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-​of-the-Art Scientific Benchmark PR Newswire
13.01.26 - PR Newswire
Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference PR Newswire
22.12.25 - PR Newswire
Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach
Ginkgo Bioworks Partners with Carnegie-​Mellon University to Develop Innovative New Cancer Screening Approach PR Newswire
17.12.25 - PR Newswire
Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment
Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment PR Newswire
09.12.25 - PR Newswire
Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety
Ginkgo Bioworks partners on Deep Origin-​led team to develop new tools for predicting drug safety PR Newswire
05.12.25 - PR Newswire
Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High‑Throughput Phenotyping Platform for DOE's M2PC
Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High‑Throughput Phenotyping Platform for DOE's M2PC PR Newswire
03.12.25 - PR Newswire
STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy
STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-​Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy PR Newswire
18.11.25 - PR Newswire
Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health
Ginkgo Bioworks Partners on Illinois-​Led Team to Develop Innovative New Treatments for Oral Health PR Newswire
06.11.25 - PR Newswire
Ginkgo Bioworks Reports Third Quarter 2025 Financial Results
Ginkgo Bioworks Reports Third Quarter 2025 Financial Results PR Newswire
03.11.25 - PR Newswire
Ginkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-Consortium
Ginkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-​Consortium PR Newswire
31.10.25 - PR Newswire
Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture
Ginkgo Bioworks and Bayer Extend Multi-​Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture PR Newswire
30.10.25 - PR Newswire
Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation
Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation PR Newswire
23.10.25 - PR Newswire
Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program
Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program PR Newswire
29.08.25 - PR Newswire
Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions
Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions PR Newswire
20.08.25 - PR Newswire
Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-in-the-loop Workflows Across the Biopharma Industry
Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-​in-the-loop Workflows Across the Biopharma Industry PR Newswire
12.08.25 - PR Newswire
Ginkgo Automation Appoints Brian O'Sullivan as Head of Commercial to Accelerate External Growth
Ginkgo Automation Appoints Brian O'Sullivan as Head of Commercial to Accelerate External Growth PR Newswire

Newssuche

Videos

newspaper
07.04.26 +5,59%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: VJ9H40 Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »